Drug · DIN 02478587
AMLODIPINE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 7, 2023; first marketed April 7, 2023.
- Drug Identification Number (DIN)
- 02478587
- Company (DIN owner)
- Sanis Health Inc.Brampton, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Amlodipine C08CA01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AMLODIPINE (AMLODIPINE BESYLATE) | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 16, 2022: NOC 28202Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Companies
- July 11, 2018: NOC 21068Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named AMLODIPINE
- DIN 02326795 · Marketed
- DIN 02326809 · Marketed
- DIN 02326817 · Marketed
- DIN 02331284 · Marketed
- DIN 02331292 · Marketed
- DIN 02385783 · Marketed
- DIN 02385791 · Marketed
- DIN 02385805 · Marketed
- DIN 02429217 · Marketed
- DIN 02429225 · Marketed
- DIN 02490781 · Marketed
- DIN 02490803 · Marketed
- DIN 02490811 · Marketed
- DIN 02492199 · Marketed
- DIN 02552868 · Marketed
- DIN 02552876 · Marketed
- DIN 02552884 · Marketed
- DIN 02343193 · Cancelled Post Market
- DIN 02343207 · Cancelled Post Market
- DIN 02343215 · Cancelled Post Market